Bookmark this page

Persistence of somatic symptoms in treated depressed patients
The prevalence of physical symptoms is high in primary care and recently a relationship between somatization and depression has been established. The majority of depressed patients complain almost exclusively of somatic symptoms. The ARTIST (a randomized trial investigating SSRI treatment) study investigated the outcomes of physical symptoms in depressed patients.
Thirty seven primary care clinics involving 87 physicians participated in this open label, intention-to-treat trial which enrolled 573 depressed patients randomized to receive one of the three selective serotonin reuptake inhibitors, fluoxetine, paroxetine, or sertraline. Physical symptoms, depression and various aspects of health-related quality of life were assessed at baseline and after 1, 3, 6, and 9 months of treatment.
Major depression was diagnosed in 74% of subjects, dysthymia in 18%, and minor depression in 8%. At baseline a third to one half of the subjects reported 13 of the 14 physical symptoms assessed, principally fatigue, sleep problems, headaches, stomach pain, and palpitations. When present, most symptoms were severe in 10% to 20% of patients. During the first month of treatment, physical symptoms greatly improved and then they plateaued with minimal resolution during the subsequent months. Depression also showed a rapid improvement over the first month, but in contrast to the physical symptoms, a continued gradual improvement followed over the next 8 months. Main effects of physical symptoms were on bodily pain, physical functioning, and general health, whereas the greatest impact of depression was on mental health, social and work functioning.
These results confirm the high prevalence of somatic symptoms that accompany depression and which, despite treatment, remain unresolved and have considerable impact on qualilty of life. Physicians should be aware of the importance of the physical symptoms and consider a higher dose of the antidepressant or switch to a different drug in order to obtain their complete remission.
Greco T, Eckert G, Kroenke K. The outcome of physical symptoms with treatment of depression. J Gen Intern Med 19: 813-818, 2004.

Disclaimer

Site conceived and produced by NeuroBiz Consulting & Communications
Copyright © Depression-WebWorld Ltd UK, 2001